NEO

14.7352.35%
WS

Warren Stone

President & COO

Mr. Warren Stone is Chief Operating Officer & President of NeoGenomics Laboratories, Inc. from April 2025. He was Chief Commercial Officer of NeoGenomics Laboratories, Inc. from 2024 to April 2025. Mr. Stone was President of Clinical Division of NeoGenomics Laboratories, Inc. from 2022 to 2024. He served as Chief Commercial Officer of NeoGenomics, Inc. since 2024 until April 1, 2025 and also serves as its President & Chief Operating Officer since April 1, 2025 and served as President of Clinical Services at NeoGenomics, Inc. since November 21, 2022 until 2024. He served as the Head of Americas at Ortho Clinical Diagnostics Holdings plc. He served as President of the Americas at Ortho-Clinical Diagnostics Inc. since November 2020. He oversaw Ortho?s commercial operations throughout North America and Latin America. He has a rich professional history of directing commercial and sales teams in a number of different capacities to build success. He has worked in the life sciences and specialty chemicals industries for over twenty-five years as a leader in commercial sales and marketing. He is experienced in navigating regional and global markets in order to produce growth, develop new strategies and ensure stakeholder needs are met. He has an established track record of building teams primed to take action and exceed goals. Prior to his time with Ortho, he served as senior vice president, research commercial Americas at MilliporeSigma since January 2016 until November 2020 a global life sciences supplier offering lab materials, technologies and services/solutions. In that capacity, He significantly increased the company?s growth trajectory, improved digitalization and led the commercial integration of EMDMillipore and Sigma Aldrich across the Americas. In his role as VP of sales for North America there, He transformed that region?s business to a customer-driven organization realizing above-market growth. In addition, during his tenure at Merck Millipore, warren held local and global commercial leadership roles in Germany, South Africa and Latin America. He serves as a board member of the Laboratory Products Association. He served as Vice President at Merck Millipore since February 2014 until November 2020. He served as Senior Vice Present Lab Essentials at Merck Millipore since January 2013 until February 2014. He served as Director at Merck KGaA, Darmstadt, Germany since January 1992 until December 2010. He studied Riverside high school in1990. He earned his Bachelor of Science in Analytical Chemistry from Witwatersrand Technikon in 1997 and his Diploma in Sales & Marketing Management from Damelin College, both located in Johannesburg, South Africa. Mr. Stone holds an MBA from Suffolk University.

Positions